Logo

Roche Launches Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel to Identify EBV Infection Staging

Share this

Roche Launches Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel to Identify EBV Infection Staging

Shots:

  • Roche launches Elecsys EBV immunoassay panel in countries accepting the CE mark. The Elecsys EBV panel consists of three immunoassays: Elecsys EBV IgM- Elecsys EBV VCA IgG- and Elecsys EBV EBNA IgG to detect Abs specific for the infection stage
  • The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample- resulting in potentially faster diagnosis for patients
  • The EBV panel can be used in other acute infections- such as missed HIV infections. Additionally- Roche will submit the regulatory filing to the US FDA for the EBV panel in future

  Ref: Roche | Image: Roche

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions